Biochemistry and Molecular Biology MPhil is an undergraduate degree at University of Lincoln, based in Lincoln, taught full-time over 1.5 years.
About this course
Biochemistry and molecular biology offer an understanding of the biological and chemical processes that allow life to thrive, giving us the tools we need to solve key challenges in cell biology, pathology, pharmacology, physiology, and genetics. This programme provides students with the opportunity to conduct research into a range of human health problems and diseases through interventions at the molecular and biochemical level.
Students benefit from training courses provided by the University aimed at developing key skills in research. Under the guidance and advice of their academic supervisors, students will also be encouraged to present talks and seminars on their work both at the University of Lincoln as well at national and international meetings and conferences, produce progress reports, develop their ability to write up work for publication in peer-reviewed journals, and, ultimately, to effectively communicate their research and thesis.
Beyond learning how to conduct research and the specialist skills that students are expected to develop within their subject discipline, the process of studying for a research degree can provide transferable skills in problem-solving, time management, independent and team work, and communication.
Study Options
This course is available in 6 study options:
Duration: 2 Years
Qualification: MPhil
Location: Lincoln
Duration: 1.5 Years
Qualification: MPhil
Location: Lincoln
Duration: 3 Years
Qualification: PhD
Location: Lincoln
Duration: 2 Years
Qualification: PhD
Location: Lincoln
Duration: 1 Year
Qualification: MSc (Res)
Location: Lincoln
Duration: 2 Years
Qualification: MSc (Res)
Location: Lincoln
Related Courses
Course Details
- Qualification
- Master of Philosophy - MPhil
- Study Mode
- Full-time
- Duration
- 1.5 Years
- Start Date
- 2025
- Academic Year
- 2025
- Campus / Location
- Lincoln
- Scheme
- Undergraduate
2025-entry data — 2026 offers may differ